Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05894655 · ClinicalTrials.gov registry record · NA
Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 6,527
- Enrollment target
NCT05894655: Completed NA study, sponsored by University of California, San Diego.
NCT05894655 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 6,527 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (365% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05894655, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,527 participants
- Enrollment target
Study Summary
Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents, the ethnic minority community most impacted by COVID-19 in San Diego. In the Phase I project, University of California, San Diego (UCSD) partnered with San Ysidro Health (SYH) and the Global Action Research Center, to co-create and demonstrate the impact of a COVID-19 testing program in San Ysidro, one of the most impacted areas from COVID-19 in San Diego County. To date, the project tested \>10,000 community members (92% Latino) and received requests to scale-out the testing program to additional primary care clinic sites. In this Phase III project, Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex) will extend work with the Phase I community and clinical partners to refine, specify, implement, and evaluate an implementation strategy bundle that optimizes COVID-19 testing, expanding beyond current polymerase chain reaction (PCR) testing to FDA-authorized COVID-19 rapid antigen testing.
Primary Outcome
The primary objective is to refine and operationalize the multi-component implementation strategy bundle and measures of implementation and sustainment success for rapid FDA-authorized COVID-19 rapid testing using the partnership with the Global Arc and Community and Scientific Advisory Board. Each session will be recorded while Global Arc partners guide the board to identify potential failures in the implementation design. Measures of success will be collected by partner engagement surveys, whi
Interventions
- BEHAVIORAL COVID-19 walk-up, on-site testing strategy
- BEHAVIORAL Community Health Worker (CHW) leading testing navigation and general preventive care reminders
- BEHAVIORAL No-cost self-testing kit vending machines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,527 participants |
| Start Date | 2023-08-28 |
| Est. Completion | 2025-10-08 |
| Phase | NA |
What the finished NCT05894655 record still lists
NCT05894655 is an interventional study that assigns participants to a tested intervention. Its 6,527 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (365% higher).
The record links to 0 conditions, and to 3 interventions - of which COVID-19 walk-up, on-site testing strategy is the first listed.
NCT05894655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05894655 about?
NCT05894655 is a clinical study titled "Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences". Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents, the ethnic minority community most impacted by COVID-...
What is the current status of trial NCT05894655?
This trial is currently completed. It is a NA study. The enrollment target is 6,527 participants. The study started on 2023-08-28. Estimated completion is 2025-10-08.
What interventions are being tested in trial NCT05894655?
The interventions under investigation include: COVID-19 walk-up, on-site testing strategy (BEHAVIORAL), Community Health Worker (CHW) leading testing navigation and general preventive care reminders (BEHAVIORAL), No-cost self-testing kit vending machines (BEHAVIORAL).
Who is sponsoring clinical trial NCT05894655?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05894655's enrollment target sits among peer trials
6,527 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI